by In2Pharma | Dec 29, 2023 | News
Belgium An update of the Royal Decree of 7 April 1995 on information and advertising for medicines for human use was published to include the degree of “Master in pharmaceutical sciences” as an acceptable degree to obtain the RIP recognition: Source: Royal Decree of 7...
by In2Pharma | Dec 29, 2023 | News
The Netherlands As previously announced, the Foundation for the Code for Pharmaceutical Advertising (“the CGR”) and the Foundation for the Code of Conduct for Medical Devices (“the GMH”) have decided to further tighten their rules as of January 1st, 2024....
by In2Pharma | Dec 7, 2023 | News
The Netherlands As of 1 January 2022, a new system came into force in the Netherlands providing for annual indexation of the reasonable maximum hourly rates for the remuneration of professionals for services rendered. We would like to inform you about the rates for...
by In2Pharma | Dec 6, 2023 | News
Europe To prevent and mitigate shortages of critical medicines in the European Union, the EU commission has adopted a couple measures. These measures aim at ensuring adequate supply of medicines or managing medicine shortages. Examples of planned measures are:...
by In2Pharma | Oct 27, 2023 | News
Belgium On 16 October, the Belgian federal agency for medicines and health products (FAMHP) has introduced a new application for the effective management of marketing authorisation and vigilance dossiers. Data Tracking System (DTS) will replace 4 MeSeA applications:...
